Concordant HIV Infection and Visceral Leishmaniasis in Ethiopia: The Influence of Antiretroviral Treatment and Other Factors on Outcome
Author(s) -
Rachel ter Horst,
Simon M. Collin,
Koert Ritmeijer,
Adey Bogale,
R.N. Davidson
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/587899
Subject(s) - medicine , visceral leishmaniasis , hazard ratio , coinfection , leishmaniasis , confidence interval , antiretroviral therapy , viral load , immunology , gastroenterology , human immunodeficiency virus (hiv)
Coinfection with human immunodeficiency virus (HIV) and Leishmania donovani visceral leishmaniasis (VL) in Africa is an emerging, poorly understood disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom